American Journal of Cardiology
Volume 81, Issue 11 , Pages 1318-1322 , 1 June 1998

Diagnostic and Prognostic Implications of Left Ventricular Cavity Obliteration Response to Dobutamine Echocardiography

  • Maria-Anna Secknus, MD

      Affiliations

    • Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Otfried N Niedermaier, MD

      Affiliations

    • Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Michael S Lauer, MD

      Affiliations

    • Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Thomas H Marwick, MD, PhD

      Affiliations

    • Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Corresponding Author InformationAddress for reprints: Thomas H. Marwick, MD, Department of Cardiology, F15, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195

Received 24 November 1997 ,Revised 15 January 1998 ,Accepted 15 January 1998.

References 

  1. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 1991;83:1605–1614
  2. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography (Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations). Mayo Clin Proc. 1995;70:16–27
  3. Cohen JL, Ottenweller JE, George AK, Duvvuri S. Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease. Am J Cardiol. 1993;72:1226–1231
  4. Dagianti A, Penco M, Agati L, Sciomer S, Rosanio S. Stress echocardiography (comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease). J Am Coll Cardiol. 1995;26:18–25
  5. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S, Stankovic G, et al. Stress echocardiography in the detection of myocardial ischemia (Head-to-head comparison of exercise, dobutamine, and dipyridamole tests). Circulation. 1994;90:1168–1176
  6. Marwick TH, D’Hondt AM, Mairesse GH, Baudhuin T, Wijns W, Detry JM. Comparative ability of dobutamine and exercise stress in inducing myocardial ischaemia in active patients. Br Heart J. 1994;72:31–38
  7. Olson CE, Porter TR, Deligonul U, Xie F, Anderson JR. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol. 1994;24:1268–1273
  8. Sawada SG, Ryan T, Conley MJ, Corya BC, Feigenbaum H, Armstrong WF. Prognostic value of a normal exercise echocardiogram. Am Heart J. 1990;120:49–55
  9. Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E, et al. Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation. 1989;80:450–457
  10. McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992;70:41–46
  11. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography (American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms). J Am Soc Echocardiogr. 1989;2:358–367
  12. Bach DS, Muller DW, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms (characterization of clinical, echocardiographic and angiographic findings). J Am Coll Cardiol. 1994;24:928–933
  13. Jones PP, Snitker S, Skinner JS, Ravussin E. Gender differences in muscle sympathetic activity (effect of body fat distribution). Am J Physiol. 1997;270:E363–E366
  14. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women (an effect of smaller chamber size). J Am Coll Cardiol. 1996;28:1214–1219
  15. Hashimoto Y, Reid CL, Gardin JM. Left ventricular cavity geometry and dynamic intracavitary left ventricular obstruction during dobutamine stress echocardiography. Am J Card Imaging. 1996;10:163–169
  16. Weissman NJ, Nidorf SM, Weyman AE, Picard MH. Effect of hydration on cavity obliteration during dobutamine stress echocardiography. Clin Cardiol. 1995;18:17–20
  17. Ballal RS, Secknus MA, Mehta R, Kapadia S, Lauer MS, Marwick TH. Cardiac outcomes in coronary patients with submaximal dobutamine stress echocardiography. Am J Cardiol. 1997;80:725–729
  18. Secknus M, Marwick TH. Influence of gender on physiologic response and accuracy of dobutamine echocardiography. Am J Cardiol. 1997;29:1234–1240
  19. Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EG, et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med. 1994;97:119–125
  20. Poldermans D, Arnese M, Fioretti PM, Boersma E, Thomson IR, Rambaldi R, et al. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation. 1997;95:53–58
  21. Marmor A, Schneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol. 1997;29:422–428

PII: S0002-9149(98)00162-3

American Journal of Cardiology
Volume 81, Issue 11 , Pages 1318-1322 , 1 June 1998

Article Tools

* Image Usage & Resolution